Global Pulmonary Administration Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Pulmonary drug delivery system is a drug delivery route that directly delivers drugs to the respiratory tract and lungs. It is mainly used to treat respiratory diseases, such as asthma, COPD and lung cancer. This method of administration has the advantages of rapid onset, good efficacy, and reduced adverse reactions.
The global Pulmonary Administration market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Pulmonary Administration Industry Forecast” looks at past sales and reviews total world Pulmonary Administration sales in 2023, providing a comprehensive analysis by region and market sector of projected Pulmonary Administration sales for 2024 through 2030. With Pulmonary Administration sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pulmonary Administration industry.
This Insight Report provides a comprehensive analysis of the global Pulmonary Administration landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pulmonary Administration portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pulmonary Administration market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pulmonary Administration and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pulmonary Administration.
United States market for Pulmonary Administration is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Pulmonary Administration is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Pulmonary Administration is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Pulmonary Administration players cover Aptar Pharma, Nemera, Porex, Chiesi Farmaceutici, AstraZeneca, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Pulmonary Administration market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Pulmonary Administration market?
What factors are driving Pulmonary Administration market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pulmonary Administration market opportunities vary by end market size?
How does Pulmonary Administration break out by Type, by Application?
Pulmonary drug delivery system is a drug delivery route that directly delivers drugs to the respiratory tract and lungs. It is mainly used to treat respiratory diseases, such as asthma, COPD and lung cancer. This method of administration has the advantages of rapid onset, good efficacy, and reduced adverse reactions.
The global Pulmonary Administration market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Pulmonary Administration Industry Forecast” looks at past sales and reviews total world Pulmonary Administration sales in 2023, providing a comprehensive analysis by region and market sector of projected Pulmonary Administration sales for 2024 through 2030. With Pulmonary Administration sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pulmonary Administration industry.
This Insight Report provides a comprehensive analysis of the global Pulmonary Administration landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pulmonary Administration portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pulmonary Administration market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pulmonary Administration and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pulmonary Administration.
United States market for Pulmonary Administration is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Pulmonary Administration is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Pulmonary Administration is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Pulmonary Administration players cover Aptar Pharma, Nemera, Porex, Chiesi Farmaceutici, AstraZeneca, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Pulmonary Administration market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Pressurized Metered Dose Inhalation System
- Dry Powder Inhalation System
- Soft Mist Inhalation System
- Others
- Bronchial Asthma
- Chronic Obstructive Pulmonary Disease
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Aptar Pharma
- Nemera
- Porex
- Chiesi Farmaceutici
- AstraZeneca
- H&T Presspart
- Gerresheimer
- Merxin Ltd
- 3M
- Aerogen Pharma
- MedPharm
- Kindeva Drug Delivery
- Boehringer Ingelheim
- Chiesi Farmaceutici SpA
- Merck & Co, Inc
- Novartis AG
- PARI international
- Vectura Group Plc
- GlaxoSmithKline
- Koninklijke Philips NV
- OMRON Corporation
- Sunovion Pharmaceuticals, Inc
- Teva Pharmaceutical Industries Ltd
- Yisuo Intelligent
What is the 10-year outlook for the global Pulmonary Administration market?
What factors are driving Pulmonary Administration market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pulmonary Administration market opportunities vary by end market size?
How does Pulmonary Administration break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pulmonary Administration Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Pulmonary Administration by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Pulmonary Administration by Country/Region, 2019, 2023 & 2030
2.2 Pulmonary Administration Segment by Type
2.2.1 Pressurized Metered Dose Inhalation System
2.2.2 Dry Powder Inhalation System
2.2.3 Soft Mist Inhalation System
2.2.4 Others
2.3 Pulmonary Administration Sales by Type
2.3.1 Global Pulmonary Administration Sales Market Share by Type (2019-2024)
2.3.2 Global Pulmonary Administration Revenue and Market Share by Type (2019-2024)
2.3.3 Global Pulmonary Administration Sale Price by Type (2019-2024)
2.4 Pulmonary Administration Segment by Application
2.4.1 Bronchial Asthma
2.4.2 Chronic Obstructive Pulmonary Disease
2.4.3 Others
2.5 Pulmonary Administration Sales by Application
2.5.1 Global Pulmonary Administration Sale Market Share by Application (2019-2024)
2.5.2 Global Pulmonary Administration Revenue and Market Share by Application (2019-2024)
2.5.3 Global Pulmonary Administration Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Pulmonary Administration Breakdown Data by Company
3.1.1 Global Pulmonary Administration Annual Sales by Company (2019-2024)
3.1.2 Global Pulmonary Administration Sales Market Share by Company (2019-2024)
3.2 Global Pulmonary Administration Annual Revenue by Company (2019-2024)
3.2.1 Global Pulmonary Administration Revenue by Company (2019-2024)
3.2.2 Global Pulmonary Administration Revenue Market Share by Company (2019-2024)
3.3 Global Pulmonary Administration Sale Price by Company
3.4 Key Manufacturers Pulmonary Administration Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pulmonary Administration Product Location Distribution
3.4.2 Players Pulmonary Administration Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PULMONARY ADMINISTRATION BY GEOGRAPHIC REGION
4.1 World Historic Pulmonary Administration Market Size by Geographic Region (2019-2024)
4.1.1 Global Pulmonary Administration Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Pulmonary Administration Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Pulmonary Administration Market Size by Country/Region (2019-2024)
4.2.1 Global Pulmonary Administration Annual Sales by Country/Region (2019-2024)
4.2.2 Global Pulmonary Administration Annual Revenue by Country/Region (2019-2024)
4.3 Americas Pulmonary Administration Sales Growth
4.4 APAC Pulmonary Administration Sales Growth
4.5 Europe Pulmonary Administration Sales Growth
4.6 Middle East & Africa Pulmonary Administration Sales Growth
5 AMERICAS
5.1 Americas Pulmonary Administration Sales by Country
5.1.1 Americas Pulmonary Administration Sales by Country (2019-2024)
5.1.2 Americas Pulmonary Administration Revenue by Country (2019-2024)
5.2 Americas Pulmonary Administration Sales by Type (2019-2024)
5.3 Americas Pulmonary Administration Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pulmonary Administration Sales by Region
6.1.1 APAC Pulmonary Administration Sales by Region (2019-2024)
6.1.2 APAC Pulmonary Administration Revenue by Region (2019-2024)
6.2 APAC Pulmonary Administration Sales by Type (2019-2024)
6.3 APAC Pulmonary Administration Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pulmonary Administration by Country
7.1.1 Europe Pulmonary Administration Sales by Country (2019-2024)
7.1.2 Europe Pulmonary Administration Revenue by Country (2019-2024)
7.2 Europe Pulmonary Administration Sales by Type (2019-2024)
7.3 Europe Pulmonary Administration Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pulmonary Administration by Country
8.1.1 Middle East & Africa Pulmonary Administration Sales by Country (2019-2024)
8.1.2 Middle East & Africa Pulmonary Administration Revenue by Country (2019-2024)
8.2 Middle East & Africa Pulmonary Administration Sales by Type (2019-2024)
8.3 Middle East & Africa Pulmonary Administration Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pulmonary Administration
10.3 Manufacturing Process Analysis of Pulmonary Administration
10.4 Industry Chain Structure of Pulmonary Administration
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pulmonary Administration Distributors
11.3 Pulmonary Administration Customer
12 WORLD FORECAST REVIEW FOR PULMONARY ADMINISTRATION BY GEOGRAPHIC REGION
12.1 Global Pulmonary Administration Market Size Forecast by Region
12.1.1 Global Pulmonary Administration Forecast by Region (2025-2030)
12.1.2 Global Pulmonary Administration Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Pulmonary Administration Forecast by Type (2025-2030)
12.7 Global Pulmonary Administration Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Aptar Pharma
13.1.1 Aptar Pharma Company Information
13.1.2 Aptar Pharma Pulmonary Administration Product Portfolios and Specifications
13.1.3 Aptar Pharma Pulmonary Administration Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Aptar Pharma Main Business Overview
13.1.5 Aptar Pharma Latest Developments
13.2 Nemera
13.2.1 Nemera Company Information
13.2.2 Nemera Pulmonary Administration Product Portfolios and Specifications
13.2.3 Nemera Pulmonary Administration Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Nemera Main Business Overview
13.2.5 Nemera Latest Developments
13.3 Porex
13.3.1 Porex Company Information
13.3.2 Porex Pulmonary Administration Product Portfolios and Specifications
13.3.3 Porex Pulmonary Administration Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Porex Main Business Overview
13.3.5 Porex Latest Developments
13.4 Chiesi Farmaceutici
13.4.1 Chiesi Farmaceutici Company Information
13.4.2 Chiesi Farmaceutici Pulmonary Administration Product Portfolios and Specifications
13.4.3 Chiesi Farmaceutici Pulmonary Administration Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Chiesi Farmaceutici Main Business Overview
13.4.5 Chiesi Farmaceutici Latest Developments
13.5 AstraZeneca
13.5.1 AstraZeneca Company Information
13.5.2 AstraZeneca Pulmonary Administration Product Portfolios and Specifications
13.5.3 AstraZeneca Pulmonary Administration Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 AstraZeneca Main Business Overview
13.5.5 AstraZeneca Latest Developments
13.6 H&T Presspart
13.6.1 H&T Presspart Company Information
13.6.2 H&T Presspart Pulmonary Administration Product Portfolios and Specifications
13.6.3 H&T Presspart Pulmonary Administration Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 H&T Presspart Main Business Overview
13.6.5 H&T Presspart Latest Developments
13.7 Gerresheimer
13.7.1 Gerresheimer Company Information
13.7.2 Gerresheimer Pulmonary Administration Product Portfolios and Specifications
13.7.3 Gerresheimer Pulmonary Administration Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Gerresheimer Main Business Overview
13.7.5 Gerresheimer Latest Developments
13.8 Merxin Ltd
13.8.1 Merxin Ltd Company Information
13.8.2 Merxin Ltd Pulmonary Administration Product Portfolios and Specifications
13.8.3 Merxin Ltd Pulmonary Administration Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Merxin Ltd Main Business Overview
13.8.5 Merxin Ltd Latest Developments
13.9 3M
13.9.1 3M Company Information
13.9.2 3M Pulmonary Administration Product Portfolios and Specifications
13.9.3 3M Pulmonary Administration Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 3M Main Business Overview
13.9.5 3M Latest Developments
13.10 Aerogen Pharma
13.10.1 Aerogen Pharma Company Information
13.10.2 Aerogen Pharma Pulmonary Administration Product Portfolios and Specifications
13.10.3 Aerogen Pharma Pulmonary Administration Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Aerogen Pharma Main Business Overview
13.10.5 Aerogen Pharma Latest Developments
13.11 MedPharm
13.11.1 MedPharm Company Information
13.11.2 MedPharm Pulmonary Administration Product Portfolios and Specifications
13.11.3 MedPharm Pulmonary Administration Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 MedPharm Main Business Overview
13.11.5 MedPharm Latest Developments
13.12 Kindeva Drug Delivery
13.12.1 Kindeva Drug Delivery Company Information
13.12.2 Kindeva Drug Delivery Pulmonary Administration Product Portfolios and Specifications
13.12.3 Kindeva Drug Delivery Pulmonary Administration Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Kindeva Drug Delivery Main Business Overview
13.12.5 Kindeva Drug Delivery Latest Developments
13.13 Boehringer Ingelheim
13.13.1 Boehringer Ingelheim Company Information
13.13.2 Boehringer Ingelheim Pulmonary Administration Product Portfolios and Specifications
13.13.3 Boehringer Ingelheim Pulmonary Administration Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Boehringer Ingelheim Main Business Overview
13.13.5 Boehringer Ingelheim Latest Developments
13.14 Chiesi Farmaceutici SpA
13.14.1 Chiesi Farmaceutici SpA Company Information
13.14.2 Chiesi Farmaceutici SpA Pulmonary Administration Product Portfolios and Specifications
13.14.3 Chiesi Farmaceutici SpA Pulmonary Administration Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Chiesi Farmaceutici SpA Main Business Overview
13.14.5 Chiesi Farmaceutici SpA Latest Developments
13.15 Merck & Co, Inc
13.15.1 Merck & Co, Inc Company Information
13.15.2 Merck & Co, Inc Pulmonary Administration Product Portfolios and Specifications
13.15.3 Merck & Co, Inc Pulmonary Administration Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Merck & Co, Inc Main Business Overview
13.15.5 Merck & Co, Inc Latest Developments
13.16 Novartis AG
13.16.1 Novartis AG Company Information
13.16.2 Novartis AG Pulmonary Administration Product Portfolios and Specifications
13.16.3 Novartis AG Pulmonary Administration Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Novartis AG Main Business Overview
13.16.5 Novartis AG Latest Developments
13.17 PARI international
13.17.1 PARI international Company Information
13.17.2 PARI international Pulmonary Administration Product Portfolios and Specifications
13.17.3 PARI international Pulmonary Administration Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 PARI international Main Business Overview
13.17.5 PARI international Latest Developments
13.18 Vectura Group Plc
13.18.1 Vectura Group Plc Company Information
13.18.2 Vectura Group Plc Pulmonary Administration Product Portfolios and Specifications
13.18.3 Vectura Group Plc Pulmonary Administration Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 Vectura Group Plc Main Business Overview
13.18.5 Vectura Group Plc Latest Developments
13.19 GlaxoSmithKline
13.19.1 GlaxoSmithKline Company Information
13.19.2 GlaxoSmithKline Pulmonary Administration Product Portfolios and Specifications
13.19.3 GlaxoSmithKline Pulmonary Administration Sales, Revenue, Price and Gross Margin (2019-2024)
13.19.4 GlaxoSmithKline Main Business Overview
13.19.5 GlaxoSmithKline Latest Developments
13.20 Koninklijke Philips NV
13.20.1 Koninklijke Philips NV Company Information
13.20.2 Koninklijke Philips NV Pulmonary Administration Product Portfolios and Specifications
13.20.3 Koninklijke Philips NV Pulmonary Administration Sales, Revenue, Price and Gross Margin (2019-2024)
13.20.4 Koninklijke Philips NV Main Business Overview
13.20.5 Koninklijke Philips NV Latest Developments
13.21 OMRON Corporation
13.21.1 OMRON Corporation Company Information
13.21.2 OMRON Corporation Pulmonary Administration Product Portfolios and Specifications
13.21.3 OMRON Corporation Pulmonary Administration Sales, Revenue, Price and Gross Margin (2019-2024)
13.21.4 OMRON Corporation Main Business Overview
13.21.5 OMRON Corporation Latest Developments
13.22 Sunovion Pharmaceuticals, Inc
13.22.1 Sunovion Pharmaceuticals, Inc Company Information
13.22.2 Sunovion Pharmaceuticals, Inc Pulmonary Administration Product Portfolios and Specifications
13.22.3 Sunovion Pharmaceuticals, Inc Pulmonary Administration Sales, Revenue, Price and Gross Margin (2019-2024)
13.22.4 Sunovion Pharmaceuticals, Inc Main Business Overview
13.22.5 Sunovion Pharmaceuticals, Inc Latest Developments
13.23 Teva Pharmaceutical Industries Ltd
13.23.1 Teva Pharmaceutical Industries Ltd Company Information
13.23.2 Teva Pharmaceutical Industries Ltd Pulmonary Administration Product Portfolios and Specifications
13.23.3 Teva Pharmaceutical Industries Ltd Pulmonary Administration Sales, Revenue, Price and Gross Margin (2019-2024)
13.23.4 Teva Pharmaceutical Industries Ltd Main Business Overview
13.23.5 Teva Pharmaceutical Industries Ltd Latest Developments
13.24 Yisuo Intelligent
13.24.1 Yisuo Intelligent Company Information
13.24.2 Yisuo Intelligent Pulmonary Administration Product Portfolios and Specifications
13.24.3 Yisuo Intelligent Pulmonary Administration Sales, Revenue, Price and Gross Margin (2019-2024)
13.24.4 Yisuo Intelligent Main Business Overview
13.24.5 Yisuo Intelligent Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pulmonary Administration Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Pulmonary Administration by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Pulmonary Administration by Country/Region, 2019, 2023 & 2030
2.2 Pulmonary Administration Segment by Type
2.2.1 Pressurized Metered Dose Inhalation System
2.2.2 Dry Powder Inhalation System
2.2.3 Soft Mist Inhalation System
2.2.4 Others
2.3 Pulmonary Administration Sales by Type
2.3.1 Global Pulmonary Administration Sales Market Share by Type (2019-2024)
2.3.2 Global Pulmonary Administration Revenue and Market Share by Type (2019-2024)
2.3.3 Global Pulmonary Administration Sale Price by Type (2019-2024)
2.4 Pulmonary Administration Segment by Application
2.4.1 Bronchial Asthma
2.4.2 Chronic Obstructive Pulmonary Disease
2.4.3 Others
2.5 Pulmonary Administration Sales by Application
2.5.1 Global Pulmonary Administration Sale Market Share by Application (2019-2024)
2.5.2 Global Pulmonary Administration Revenue and Market Share by Application (2019-2024)
2.5.3 Global Pulmonary Administration Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Pulmonary Administration Breakdown Data by Company
3.1.1 Global Pulmonary Administration Annual Sales by Company (2019-2024)
3.1.2 Global Pulmonary Administration Sales Market Share by Company (2019-2024)
3.2 Global Pulmonary Administration Annual Revenue by Company (2019-2024)
3.2.1 Global Pulmonary Administration Revenue by Company (2019-2024)
3.2.2 Global Pulmonary Administration Revenue Market Share by Company (2019-2024)
3.3 Global Pulmonary Administration Sale Price by Company
3.4 Key Manufacturers Pulmonary Administration Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pulmonary Administration Product Location Distribution
3.4.2 Players Pulmonary Administration Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PULMONARY ADMINISTRATION BY GEOGRAPHIC REGION
4.1 World Historic Pulmonary Administration Market Size by Geographic Region (2019-2024)
4.1.1 Global Pulmonary Administration Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Pulmonary Administration Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Pulmonary Administration Market Size by Country/Region (2019-2024)
4.2.1 Global Pulmonary Administration Annual Sales by Country/Region (2019-2024)
4.2.2 Global Pulmonary Administration Annual Revenue by Country/Region (2019-2024)
4.3 Americas Pulmonary Administration Sales Growth
4.4 APAC Pulmonary Administration Sales Growth
4.5 Europe Pulmonary Administration Sales Growth
4.6 Middle East & Africa Pulmonary Administration Sales Growth
5 AMERICAS
5.1 Americas Pulmonary Administration Sales by Country
5.1.1 Americas Pulmonary Administration Sales by Country (2019-2024)
5.1.2 Americas Pulmonary Administration Revenue by Country (2019-2024)
5.2 Americas Pulmonary Administration Sales by Type (2019-2024)
5.3 Americas Pulmonary Administration Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pulmonary Administration Sales by Region
6.1.1 APAC Pulmonary Administration Sales by Region (2019-2024)
6.1.2 APAC Pulmonary Administration Revenue by Region (2019-2024)
6.2 APAC Pulmonary Administration Sales by Type (2019-2024)
6.3 APAC Pulmonary Administration Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pulmonary Administration by Country
7.1.1 Europe Pulmonary Administration Sales by Country (2019-2024)
7.1.2 Europe Pulmonary Administration Revenue by Country (2019-2024)
7.2 Europe Pulmonary Administration Sales by Type (2019-2024)
7.3 Europe Pulmonary Administration Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pulmonary Administration by Country
8.1.1 Middle East & Africa Pulmonary Administration Sales by Country (2019-2024)
8.1.2 Middle East & Africa Pulmonary Administration Revenue by Country (2019-2024)
8.2 Middle East & Africa Pulmonary Administration Sales by Type (2019-2024)
8.3 Middle East & Africa Pulmonary Administration Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pulmonary Administration
10.3 Manufacturing Process Analysis of Pulmonary Administration
10.4 Industry Chain Structure of Pulmonary Administration
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pulmonary Administration Distributors
11.3 Pulmonary Administration Customer
12 WORLD FORECAST REVIEW FOR PULMONARY ADMINISTRATION BY GEOGRAPHIC REGION
12.1 Global Pulmonary Administration Market Size Forecast by Region
12.1.1 Global Pulmonary Administration Forecast by Region (2025-2030)
12.1.2 Global Pulmonary Administration Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Pulmonary Administration Forecast by Type (2025-2030)
12.7 Global Pulmonary Administration Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Aptar Pharma
13.1.1 Aptar Pharma Company Information
13.1.2 Aptar Pharma Pulmonary Administration Product Portfolios and Specifications
13.1.3 Aptar Pharma Pulmonary Administration Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Aptar Pharma Main Business Overview
13.1.5 Aptar Pharma Latest Developments
13.2 Nemera
13.2.1 Nemera Company Information
13.2.2 Nemera Pulmonary Administration Product Portfolios and Specifications
13.2.3 Nemera Pulmonary Administration Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Nemera Main Business Overview
13.2.5 Nemera Latest Developments
13.3 Porex
13.3.1 Porex Company Information
13.3.2 Porex Pulmonary Administration Product Portfolios and Specifications
13.3.3 Porex Pulmonary Administration Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Porex Main Business Overview
13.3.5 Porex Latest Developments
13.4 Chiesi Farmaceutici
13.4.1 Chiesi Farmaceutici Company Information
13.4.2 Chiesi Farmaceutici Pulmonary Administration Product Portfolios and Specifications
13.4.3 Chiesi Farmaceutici Pulmonary Administration Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Chiesi Farmaceutici Main Business Overview
13.4.5 Chiesi Farmaceutici Latest Developments
13.5 AstraZeneca
13.5.1 AstraZeneca Company Information
13.5.2 AstraZeneca Pulmonary Administration Product Portfolios and Specifications
13.5.3 AstraZeneca Pulmonary Administration Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 AstraZeneca Main Business Overview
13.5.5 AstraZeneca Latest Developments
13.6 H&T Presspart
13.6.1 H&T Presspart Company Information
13.6.2 H&T Presspart Pulmonary Administration Product Portfolios and Specifications
13.6.3 H&T Presspart Pulmonary Administration Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 H&T Presspart Main Business Overview
13.6.5 H&T Presspart Latest Developments
13.7 Gerresheimer
13.7.1 Gerresheimer Company Information
13.7.2 Gerresheimer Pulmonary Administration Product Portfolios and Specifications
13.7.3 Gerresheimer Pulmonary Administration Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Gerresheimer Main Business Overview
13.7.5 Gerresheimer Latest Developments
13.8 Merxin Ltd
13.8.1 Merxin Ltd Company Information
13.8.2 Merxin Ltd Pulmonary Administration Product Portfolios and Specifications
13.8.3 Merxin Ltd Pulmonary Administration Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Merxin Ltd Main Business Overview
13.8.5 Merxin Ltd Latest Developments
13.9 3M
13.9.1 3M Company Information
13.9.2 3M Pulmonary Administration Product Portfolios and Specifications
13.9.3 3M Pulmonary Administration Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 3M Main Business Overview
13.9.5 3M Latest Developments
13.10 Aerogen Pharma
13.10.1 Aerogen Pharma Company Information
13.10.2 Aerogen Pharma Pulmonary Administration Product Portfolios and Specifications
13.10.3 Aerogen Pharma Pulmonary Administration Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Aerogen Pharma Main Business Overview
13.10.5 Aerogen Pharma Latest Developments
13.11 MedPharm
13.11.1 MedPharm Company Information
13.11.2 MedPharm Pulmonary Administration Product Portfolios and Specifications
13.11.3 MedPharm Pulmonary Administration Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 MedPharm Main Business Overview
13.11.5 MedPharm Latest Developments
13.12 Kindeva Drug Delivery
13.12.1 Kindeva Drug Delivery Company Information
13.12.2 Kindeva Drug Delivery Pulmonary Administration Product Portfolios and Specifications
13.12.3 Kindeva Drug Delivery Pulmonary Administration Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Kindeva Drug Delivery Main Business Overview
13.12.5 Kindeva Drug Delivery Latest Developments
13.13 Boehringer Ingelheim
13.13.1 Boehringer Ingelheim Company Information
13.13.2 Boehringer Ingelheim Pulmonary Administration Product Portfolios and Specifications
13.13.3 Boehringer Ingelheim Pulmonary Administration Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Boehringer Ingelheim Main Business Overview
13.13.5 Boehringer Ingelheim Latest Developments
13.14 Chiesi Farmaceutici SpA
13.14.1 Chiesi Farmaceutici SpA Company Information
13.14.2 Chiesi Farmaceutici SpA Pulmonary Administration Product Portfolios and Specifications
13.14.3 Chiesi Farmaceutici SpA Pulmonary Administration Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Chiesi Farmaceutici SpA Main Business Overview
13.14.5 Chiesi Farmaceutici SpA Latest Developments
13.15 Merck & Co, Inc
13.15.1 Merck & Co, Inc Company Information
13.15.2 Merck & Co, Inc Pulmonary Administration Product Portfolios and Specifications
13.15.3 Merck & Co, Inc Pulmonary Administration Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Merck & Co, Inc Main Business Overview
13.15.5 Merck & Co, Inc Latest Developments
13.16 Novartis AG
13.16.1 Novartis AG Company Information
13.16.2 Novartis AG Pulmonary Administration Product Portfolios and Specifications
13.16.3 Novartis AG Pulmonary Administration Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Novartis AG Main Business Overview
13.16.5 Novartis AG Latest Developments
13.17 PARI international
13.17.1 PARI international Company Information
13.17.2 PARI international Pulmonary Administration Product Portfolios and Specifications
13.17.3 PARI international Pulmonary Administration Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 PARI international Main Business Overview
13.17.5 PARI international Latest Developments
13.18 Vectura Group Plc
13.18.1 Vectura Group Plc Company Information
13.18.2 Vectura Group Plc Pulmonary Administration Product Portfolios and Specifications
13.18.3 Vectura Group Plc Pulmonary Administration Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 Vectura Group Plc Main Business Overview
13.18.5 Vectura Group Plc Latest Developments
13.19 GlaxoSmithKline
13.19.1 GlaxoSmithKline Company Information
13.19.2 GlaxoSmithKline Pulmonary Administration Product Portfolios and Specifications
13.19.3 GlaxoSmithKline Pulmonary Administration Sales, Revenue, Price and Gross Margin (2019-2024)
13.19.4 GlaxoSmithKline Main Business Overview
13.19.5 GlaxoSmithKline Latest Developments
13.20 Koninklijke Philips NV
13.20.1 Koninklijke Philips NV Company Information
13.20.2 Koninklijke Philips NV Pulmonary Administration Product Portfolios and Specifications
13.20.3 Koninklijke Philips NV Pulmonary Administration Sales, Revenue, Price and Gross Margin (2019-2024)
13.20.4 Koninklijke Philips NV Main Business Overview
13.20.5 Koninklijke Philips NV Latest Developments
13.21 OMRON Corporation
13.21.1 OMRON Corporation Company Information
13.21.2 OMRON Corporation Pulmonary Administration Product Portfolios and Specifications
13.21.3 OMRON Corporation Pulmonary Administration Sales, Revenue, Price and Gross Margin (2019-2024)
13.21.4 OMRON Corporation Main Business Overview
13.21.5 OMRON Corporation Latest Developments
13.22 Sunovion Pharmaceuticals, Inc
13.22.1 Sunovion Pharmaceuticals, Inc Company Information
13.22.2 Sunovion Pharmaceuticals, Inc Pulmonary Administration Product Portfolios and Specifications
13.22.3 Sunovion Pharmaceuticals, Inc Pulmonary Administration Sales, Revenue, Price and Gross Margin (2019-2024)
13.22.4 Sunovion Pharmaceuticals, Inc Main Business Overview
13.22.5 Sunovion Pharmaceuticals, Inc Latest Developments
13.23 Teva Pharmaceutical Industries Ltd
13.23.1 Teva Pharmaceutical Industries Ltd Company Information
13.23.2 Teva Pharmaceutical Industries Ltd Pulmonary Administration Product Portfolios and Specifications
13.23.3 Teva Pharmaceutical Industries Ltd Pulmonary Administration Sales, Revenue, Price and Gross Margin (2019-2024)
13.23.4 Teva Pharmaceutical Industries Ltd Main Business Overview
13.23.5 Teva Pharmaceutical Industries Ltd Latest Developments
13.24 Yisuo Intelligent
13.24.1 Yisuo Intelligent Company Information
13.24.2 Yisuo Intelligent Pulmonary Administration Product Portfolios and Specifications
13.24.3 Yisuo Intelligent Pulmonary Administration Sales, Revenue, Price and Gross Margin (2019-2024)
13.24.4 Yisuo Intelligent Main Business Overview
13.24.5 Yisuo Intelligent Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Pulmonary Administration Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Pulmonary Administration Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Pressurized Metered Dose Inhalation System
Table 4. Major Players of Dry Powder Inhalation System
Table 5. Major Players of Soft Mist Inhalation System
Table 6. Major Players of Others
Table 7. Global Pulmonary Administration Sales by Type (2019-2024) & (K Units)
Table 8. Global Pulmonary Administration Sales Market Share by Type (2019-2024)
Table 9. Global Pulmonary Administration Revenue by Type (2019-2024) & ($ million)
Table 10. Global Pulmonary Administration Revenue Market Share by Type (2019-2024)
Table 11. Global Pulmonary Administration Sale Price by Type (2019-2024) & (US$/Unit)
Table 12. Global Pulmonary Administration Sale by Application (2019-2024) & (K Units)
Table 13. Global Pulmonary Administration Sale Market Share by Application (2019-2024)
Table 14. Global Pulmonary Administration Revenue by Application (2019-2024) & ($ million)
Table 15. Global Pulmonary Administration Revenue Market Share by Application (2019-2024)
Table 16. Global Pulmonary Administration Sale Price by Application (2019-2024) & (US$/Unit)
Table 17. Global Pulmonary Administration Sales by Company (2019-2024) & (K Units)
Table 18. Global Pulmonary Administration Sales Market Share by Company (2019-2024)
Table 19. Global Pulmonary Administration Revenue by Company (2019-2024) & ($ millions)
Table 20. Global Pulmonary Administration Revenue Market Share by Company (2019-2024)
Table 21. Global Pulmonary Administration Sale Price by Company (2019-2024) & (US$/Unit)
Table 22. Key Manufacturers Pulmonary Administration Producing Area Distribution and Sales Area
Table 23. Players Pulmonary Administration Products Offered
Table 24. Pulmonary Administration Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Pulmonary Administration Sales by Geographic Region (2019-2024) & (K Units)
Table 28. Global Pulmonary Administration Sales Market Share Geographic Region (2019-2024)
Table 29. Global Pulmonary Administration Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Pulmonary Administration Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Pulmonary Administration Sales by Country/Region (2019-2024) & (K Units)
Table 32. Global Pulmonary Administration Sales Market Share by Country/Region (2019-2024)
Table 33. Global Pulmonary Administration Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Pulmonary Administration Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Pulmonary Administration Sales by Country (2019-2024) & (K Units)
Table 36. Americas Pulmonary Administration Sales Market Share by Country (2019-2024)
Table 37. Americas Pulmonary Administration Revenue by Country (2019-2024) & ($ millions)
Table 38. Americas Pulmonary Administration Sales by Type (2019-2024) & (K Units)
Table 39. Americas Pulmonary Administration Sales by Application (2019-2024) & (K Units)
Table 40. APAC Pulmonary Administration Sales by Region (2019-2024) & (K Units)
Table 41. APAC Pulmonary Administration Sales Market Share by Region (2019-2024)
Table 42. APAC Pulmonary Administration Revenue by Region (2019-2024) & ($ millions)
Table 43. APAC Pulmonary Administration Sales by Type (2019-2024) & (K Units)
Table 44. APAC Pulmonary Administration Sales by Application (2019-2024) & (K Units)
Table 45. Europe Pulmonary Administration Sales by Country (2019-2024) & (K Units)
Table 46. Europe Pulmonary Administration Revenue by Country (2019-2024) & ($ millions)
Table 47. Europe Pulmonary Administration Sales by Type (2019-2024) & (K Units)
Table 48. Europe Pulmonary Administration Sales by Application (2019-2024) & (K Units)
Table 49. Middle East & Africa Pulmonary Administration Sales by Country (2019-2024) & (K Units)
Table 50. Middle East & Africa Pulmonary Administration Revenue Market Share by Country (2019-2024)
Table 51. Middle East & Africa Pulmonary Administration Sales by Type (2019-2024) & (K Units)
Table 52. Middle East & Africa Pulmonary Administration Sales by Application (2019-2024) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Pulmonary Administration
Table 54. Key Market Challenges & Risks of Pulmonary Administration
Table 55. Key Industry Trends of Pulmonary Administration
Table 56. Pulmonary Administration Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Pulmonary Administration Distributors List
Table 59. Pulmonary Administration Customer List
Table 60. Global Pulmonary Administration Sales Forecast by Region (2025-2030) & (K Units)
Table 61. Global Pulmonary Administration Revenue Forecast by Region (2025-2030) & ($ millions)
Table 62. Americas Pulmonary Administration Sales Forecast by Country (2025-2030) & (K Units)
Table 63. Americas Pulmonary Administration Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 64. APAC Pulmonary Administration Sales Forecast by Region (2025-2030) & (K Units)
Table 65. APAC Pulmonary Administration Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Europe Pulmonary Administration Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Europe Pulmonary Administration Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. Middle East & Africa Pulmonary Administration Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Middle East & Africa Pulmonary Administration Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. Global Pulmonary Administration Sales Forecast by Type (2025-2030) & (K Units)
Table 71. Global Pulmonary Administration Revenue Forecast by Type (2025-2030) & ($ millions)
Table 72. Global Pulmonary Administration Sales Forecast by Application (2025-2030) & (K Units)
Table 73. Global Pulmonary Administration Revenue Forecast by Application (2025-2030) & ($ millions)
Table 74. Aptar Pharma Basic Information, Pulmonary Administration Manufacturing Base, Sales Area and Its Competitors
Table 75. Aptar Pharma Pulmonary Administration Product Portfolios and Specifications
Table 76. Aptar Pharma Pulmonary Administration Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 77. Aptar Pharma Main Business
Table 78. Aptar Pharma Latest Developments
Table 79. Nemera Basic Information, Pulmonary Administration Manufacturing Base, Sales Area and Its Competitors
Table 80. Nemera Pulmonary Administration Product Portfolios and Specifications
Table 81. Nemera Pulmonary Administration Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 82. Nemera Main Business
Table 83. Nemera Latest Developments
Table 84. Porex Basic Information, Pulmonary Administration Manufacturing Base, Sales Area and Its Competitors
Table 85. Porex Pulmonary Administration Product Portfolios and Specifications
Table 86. Porex Pulmonary Administration Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 87. Porex Main Business
Table 88. Porex Latest Developments
Table 89. Chiesi Farmaceutici Basic Information, Pulmonary Administration Manufacturing Base, Sales Area and Its Competitors
Table 90. Chiesi Farmaceutici Pulmonary Administration Product Portfolios and Specifications
Table 91. Chiesi Farmaceutici Pulmonary Administration Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 92. Chiesi Farmaceutici Main Business
Table 93. Chiesi Farmaceutici Latest Developments
Table 94. AstraZeneca Basic Information, Pulmonary Administration Manufacturing Base, Sales Area and Its Competitors
Table 95. AstraZeneca Pulmonary Administration Product Portfolios and Specifications
Table 96. AstraZeneca Pulmonary Administration Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 97. AstraZeneca Main Business
Table 98. AstraZeneca Latest Developments
Table 99. H&T Presspart Basic Information, Pulmonary Administration Manufacturing Base, Sales Area and Its Competitors
Table 100. H&T Presspart Pulmonary Administration Product Portfolios and Specifications
Table 101. H&T Presspart Pulmonary Administration Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 102. H&T Presspart Main Business
Table 103. H&T Presspart Latest Developments
Table 104. Gerresheimer Basic Information, Pulmonary Administration Manufacturing Base, Sales Area and Its Competitors
Table 105. Gerresheimer Pulmonary Administration Product Portfolios and Specifications
Table 106. Gerresheimer Pulmonary Administration Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 107. Gerresheimer Main Business
Table 108. Gerresheimer Latest Developments
Table 109. Merxin Ltd Basic Information, Pulmonary Administration Manufacturing Base, Sales Area and Its Competitors
Table 110. Merxin Ltd Pulmonary Administration Product Portfolios and Specifications
Table 111. Merxin Ltd Pulmonary Administration Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 112. Merxin Ltd Main Business
Table 113. Merxin Ltd Latest Developments
Table 114. 3M Basic Information, Pulmonary Administration Manufacturing Base, Sales Area and Its Competitors
Table 115. 3M Pulmonary Administration Product Portfolios and Specifications
Table 116. 3M Pulmonary Administration Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 117. 3M Main Business
Table 118. 3M Latest Developments
Table 119. Aerogen Pharma Basic Information, Pulmonary Administration Manufacturing Base, Sales Area and Its Competitors
Table 120. Aerogen Pharma Pulmonary Administration Product Portfolios and Specifications
Table 121. Aerogen Pharma Pulmonary Administration Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 122. Aerogen Pharma Main Business
Table 123. Aerogen Pharma Latest Developments
Table 124. MedPharm Basic Information, Pulmonary Administration Manufacturing Base, Sales Area and Its Competitors
Table 125. MedPharm Pulmonary Administration Product Portfolios and Specifications
Table 126. MedPharm Pulmonary Administration Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 127. MedPharm Main Business
Table 128. MedPharm Latest Developments
Table 129. Kindeva Drug Delivery Basic Information, Pulmonary Administration Manufacturing Base, Sales Area and Its Competitors
Table 130. Kindeva Drug Delivery Pulmonary Administration Product Portfolios and Specifications
Table 131. Kindeva Drug Delivery Pulmonary Administration Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 132. Kindeva Drug Delivery Main Business
Table 133. Kindeva Drug Delivery Latest Developments
Table 134. Boehringer Ingelheim Basic Information, Pulmonary Administration Manufacturing Base, Sales Area and Its Competitors
Table 135. Boehringer Ingelheim Pulmonary Administration Product Portfolios and Specifications
Table 136. Boehringer Ingelheim Pulmonary Administration Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 137. Boehringer Ingelheim Main Business
Table 138. Boehringer Ingelheim Latest Developments
Table 139. Chiesi Farmaceutici SpA Basic Information, Pulmonary Administration Manufacturing Base, Sales Area and Its Competitors
Table 140. Chiesi Farmaceutici SpA Pulmonary Administration Product Portfolios and Specifications
Table 141. Chiesi Farmaceutici SpA Pulmonary Administration Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 142. Chiesi Farmaceutici SpA Main Business
Table 143. Chiesi Farmaceutici SpA Latest Developments
Table 144. Merck & Co, Inc Basic Information, Pulmonary Administration Manufacturing Base, Sales Area and Its Competitors
Table 145. Merck & Co, Inc Pulmonary Administration Product Portfolios and Specifications
Table 146. Merck & Co, Inc Pulmonary Administration Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 147. Merck & Co, Inc Main Business
Table 148. Merck & Co, Inc Latest Developments
Table 149. Novartis AG Basic Information, Pulmonary Administration Manufacturing Base, Sales Area and Its Competitors
Table 150. Novartis AG Pulmonary Administration Product Portfolios and Specifications
Table 151. Novartis AG Pulmonary Administration Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 152. Novartis AG Main Business
Table 153. Novartis AG Latest Developments
Table 154. PARI international Basic Information, Pulmonary Administration Manufacturing Base, Sales Area and Its Competitors
Table 155. PARI international Pulmonary Administration Product Portfolios and Specifications
Table 156. PARI international Pulmonary Administration Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 157. PARI international Main Business
Table 158. PARI international Latest Developments
Table 159. Vectura Group Plc Basic Information, Pulmonary Administration Manufacturing Base, Sales Area and Its Competitors
Table 160. Vectura Group Plc Pulmonary Administration Product Portfolios and Specifications
Table 161. Vectura Group Plc Pulmonary Administration Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 162. Vectura Group Plc Main Business
Table 163. Vectura Group Plc Latest Developments
Table 164. GlaxoSmithKline Basic Information, Pulmonary Administration Manufacturing Base, Sales Area and Its Competitors
Table 165. GlaxoSmithKline Pulmonary Administration Product Portfolios and Specifications
Table 166. GlaxoSmithKline Pulmonary Administration Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 167. GlaxoSmithKline Main Business
Table 168. GlaxoSmithKline Latest Developments
Table 169. Koninklijke Philips NV Basic Information, Pulmonary Administration Manufacturing Base, Sales Area and Its Competitors
Table 170. Koninklijke Philips NV Pulmonary Administration Product Portfolios and Specifications
Table 171. Koninklijke Philips NV Pulmonary Administration Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 172. Koninklijke Philips NV Main Business
Table 173. Koninklijke Philips NV Latest Developments
Table 174. OMRON Corporation Basic Information, Pulmonary Administration Manufacturing Base, Sales Area and Its Competitors
Table 175. OMRON Corporation Pulmonary Administration Product Portfolios and Specifications
Table 176. OMRON Corporation Pulmonary Administration Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 177. OMRON Corporation Main Business
Table 178. OMRON Corporation Latest Developments
Table 179. Sunovion Pharmaceuticals, Inc Basic Information, Pulmonary Administration Manufacturing Base, Sales Area and Its Competitors
Table 180. Sunovion Pharmaceuticals, Inc Pulmonary Administration Product Portfolios and Specifications
Table 181. Sunovion Pharmaceuticals, Inc Pulmonary Administration Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 182. Sunovion Pharmaceuticals, Inc Main Business
Table 183. Sunovion Pharmaceuticals, Inc Latest Developments
Table 184. Teva Pharmaceutical Industries Ltd Basic Information, Pulmonary Administration Manufacturing Base, Sales Area and Its Competitors
Table 185. Teva Pharmaceutical Industries Ltd Pulmonary Administration Product Portfolios and Specifications
Table 186. Teva Pharmaceutical Industries Ltd Pulmonary Administration Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 187. Teva Pharmaceutical Industries Ltd Main Business
Table 188. Teva Pharmaceutical Industries Ltd Latest Developments
Table 189. Yisuo Intelligent Basic Information, Pulmonary Administration Manufacturing Base, Sales Area and Its Competitors
Table 190. Yisuo Intelligent Pulmonary Administration Product Portfolios and Specifications
Table 191. Yisuo Intelligent Pulmonary Administration Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 192. Yisuo Intelligent Main Business
Table 193. Yisuo Intelligent Latest Developments
Table 1. Pulmonary Administration Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Pulmonary Administration Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Pressurized Metered Dose Inhalation System
Table 4. Major Players of Dry Powder Inhalation System
Table 5. Major Players of Soft Mist Inhalation System
Table 6. Major Players of Others
Table 7. Global Pulmonary Administration Sales by Type (2019-2024) & (K Units)
Table 8. Global Pulmonary Administration Sales Market Share by Type (2019-2024)
Table 9. Global Pulmonary Administration Revenue by Type (2019-2024) & ($ million)
Table 10. Global Pulmonary Administration Revenue Market Share by Type (2019-2024)
Table 11. Global Pulmonary Administration Sale Price by Type (2019-2024) & (US$/Unit)
Table 12. Global Pulmonary Administration Sale by Application (2019-2024) & (K Units)
Table 13. Global Pulmonary Administration Sale Market Share by Application (2019-2024)
Table 14. Global Pulmonary Administration Revenue by Application (2019-2024) & ($ million)
Table 15. Global Pulmonary Administration Revenue Market Share by Application (2019-2024)
Table 16. Global Pulmonary Administration Sale Price by Application (2019-2024) & (US$/Unit)
Table 17. Global Pulmonary Administration Sales by Company (2019-2024) & (K Units)
Table 18. Global Pulmonary Administration Sales Market Share by Company (2019-2024)
Table 19. Global Pulmonary Administration Revenue by Company (2019-2024) & ($ millions)
Table 20. Global Pulmonary Administration Revenue Market Share by Company (2019-2024)
Table 21. Global Pulmonary Administration Sale Price by Company (2019-2024) & (US$/Unit)
Table 22. Key Manufacturers Pulmonary Administration Producing Area Distribution and Sales Area
Table 23. Players Pulmonary Administration Products Offered
Table 24. Pulmonary Administration Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Pulmonary Administration Sales by Geographic Region (2019-2024) & (K Units)
Table 28. Global Pulmonary Administration Sales Market Share Geographic Region (2019-2024)
Table 29. Global Pulmonary Administration Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Pulmonary Administration Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Pulmonary Administration Sales by Country/Region (2019-2024) & (K Units)
Table 32. Global Pulmonary Administration Sales Market Share by Country/Region (2019-2024)
Table 33. Global Pulmonary Administration Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Pulmonary Administration Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Pulmonary Administration Sales by Country (2019-2024) & (K Units)
Table 36. Americas Pulmonary Administration Sales Market Share by Country (2019-2024)
Table 37. Americas Pulmonary Administration Revenue by Country (2019-2024) & ($ millions)
Table 38. Americas Pulmonary Administration Sales by Type (2019-2024) & (K Units)
Table 39. Americas Pulmonary Administration Sales by Application (2019-2024) & (K Units)
Table 40. APAC Pulmonary Administration Sales by Region (2019-2024) & (K Units)
Table 41. APAC Pulmonary Administration Sales Market Share by Region (2019-2024)
Table 42. APAC Pulmonary Administration Revenue by Region (2019-2024) & ($ millions)
Table 43. APAC Pulmonary Administration Sales by Type (2019-2024) & (K Units)
Table 44. APAC Pulmonary Administration Sales by Application (2019-2024) & (K Units)
Table 45. Europe Pulmonary Administration Sales by Country (2019-2024) & (K Units)
Table 46. Europe Pulmonary Administration Revenue by Country (2019-2024) & ($ millions)
Table 47. Europe Pulmonary Administration Sales by Type (2019-2024) & (K Units)
Table 48. Europe Pulmonary Administration Sales by Application (2019-2024) & (K Units)
Table 49. Middle East & Africa Pulmonary Administration Sales by Country (2019-2024) & (K Units)
Table 50. Middle East & Africa Pulmonary Administration Revenue Market Share by Country (2019-2024)
Table 51. Middle East & Africa Pulmonary Administration Sales by Type (2019-2024) & (K Units)
Table 52. Middle East & Africa Pulmonary Administration Sales by Application (2019-2024) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Pulmonary Administration
Table 54. Key Market Challenges & Risks of Pulmonary Administration
Table 55. Key Industry Trends of Pulmonary Administration
Table 56. Pulmonary Administration Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Pulmonary Administration Distributors List
Table 59. Pulmonary Administration Customer List
Table 60. Global Pulmonary Administration Sales Forecast by Region (2025-2030) & (K Units)
Table 61. Global Pulmonary Administration Revenue Forecast by Region (2025-2030) & ($ millions)
Table 62. Americas Pulmonary Administration Sales Forecast by Country (2025-2030) & (K Units)
Table 63. Americas Pulmonary Administration Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 64. APAC Pulmonary Administration Sales Forecast by Region (2025-2030) & (K Units)
Table 65. APAC Pulmonary Administration Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Europe Pulmonary Administration Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Europe Pulmonary Administration Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. Middle East & Africa Pulmonary Administration Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Middle East & Africa Pulmonary Administration Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. Global Pulmonary Administration Sales Forecast by Type (2025-2030) & (K Units)
Table 71. Global Pulmonary Administration Revenue Forecast by Type (2025-2030) & ($ millions)
Table 72. Global Pulmonary Administration Sales Forecast by Application (2025-2030) & (K Units)
Table 73. Global Pulmonary Administration Revenue Forecast by Application (2025-2030) & ($ millions)
Table 74. Aptar Pharma Basic Information, Pulmonary Administration Manufacturing Base, Sales Area and Its Competitors
Table 75. Aptar Pharma Pulmonary Administration Product Portfolios and Specifications
Table 76. Aptar Pharma Pulmonary Administration Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 77. Aptar Pharma Main Business
Table 78. Aptar Pharma Latest Developments
Table 79. Nemera Basic Information, Pulmonary Administration Manufacturing Base, Sales Area and Its Competitors
Table 80. Nemera Pulmonary Administration Product Portfolios and Specifications
Table 81. Nemera Pulmonary Administration Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 82. Nemera Main Business
Table 83. Nemera Latest Developments
Table 84. Porex Basic Information, Pulmonary Administration Manufacturing Base, Sales Area and Its Competitors
Table 85. Porex Pulmonary Administration Product Portfolios and Specifications
Table 86. Porex Pulmonary Administration Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 87. Porex Main Business
Table 88. Porex Latest Developments
Table 89. Chiesi Farmaceutici Basic Information, Pulmonary Administration Manufacturing Base, Sales Area and Its Competitors
Table 90. Chiesi Farmaceutici Pulmonary Administration Product Portfolios and Specifications
Table 91. Chiesi Farmaceutici Pulmonary Administration Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 92. Chiesi Farmaceutici Main Business
Table 93. Chiesi Farmaceutici Latest Developments
Table 94. AstraZeneca Basic Information, Pulmonary Administration Manufacturing Base, Sales Area and Its Competitors
Table 95. AstraZeneca Pulmonary Administration Product Portfolios and Specifications
Table 96. AstraZeneca Pulmonary Administration Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 97. AstraZeneca Main Business
Table 98. AstraZeneca Latest Developments
Table 99. H&T Presspart Basic Information, Pulmonary Administration Manufacturing Base, Sales Area and Its Competitors
Table 100. H&T Presspart Pulmonary Administration Product Portfolios and Specifications
Table 101. H&T Presspart Pulmonary Administration Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 102. H&T Presspart Main Business
Table 103. H&T Presspart Latest Developments
Table 104. Gerresheimer Basic Information, Pulmonary Administration Manufacturing Base, Sales Area and Its Competitors
Table 105. Gerresheimer Pulmonary Administration Product Portfolios and Specifications
Table 106. Gerresheimer Pulmonary Administration Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 107. Gerresheimer Main Business
Table 108. Gerresheimer Latest Developments
Table 109. Merxin Ltd Basic Information, Pulmonary Administration Manufacturing Base, Sales Area and Its Competitors
Table 110. Merxin Ltd Pulmonary Administration Product Portfolios and Specifications
Table 111. Merxin Ltd Pulmonary Administration Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 112. Merxin Ltd Main Business
Table 113. Merxin Ltd Latest Developments
Table 114. 3M Basic Information, Pulmonary Administration Manufacturing Base, Sales Area and Its Competitors
Table 115. 3M Pulmonary Administration Product Portfolios and Specifications
Table 116. 3M Pulmonary Administration Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 117. 3M Main Business
Table 118. 3M Latest Developments
Table 119. Aerogen Pharma Basic Information, Pulmonary Administration Manufacturing Base, Sales Area and Its Competitors
Table 120. Aerogen Pharma Pulmonary Administration Product Portfolios and Specifications
Table 121. Aerogen Pharma Pulmonary Administration Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 122. Aerogen Pharma Main Business
Table 123. Aerogen Pharma Latest Developments
Table 124. MedPharm Basic Information, Pulmonary Administration Manufacturing Base, Sales Area and Its Competitors
Table 125. MedPharm Pulmonary Administration Product Portfolios and Specifications
Table 126. MedPharm Pulmonary Administration Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 127. MedPharm Main Business
Table 128. MedPharm Latest Developments
Table 129. Kindeva Drug Delivery Basic Information, Pulmonary Administration Manufacturing Base, Sales Area and Its Competitors
Table 130. Kindeva Drug Delivery Pulmonary Administration Product Portfolios and Specifications
Table 131. Kindeva Drug Delivery Pulmonary Administration Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 132. Kindeva Drug Delivery Main Business
Table 133. Kindeva Drug Delivery Latest Developments
Table 134. Boehringer Ingelheim Basic Information, Pulmonary Administration Manufacturing Base, Sales Area and Its Competitors
Table 135. Boehringer Ingelheim Pulmonary Administration Product Portfolios and Specifications
Table 136. Boehringer Ingelheim Pulmonary Administration Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 137. Boehringer Ingelheim Main Business
Table 138. Boehringer Ingelheim Latest Developments
Table 139. Chiesi Farmaceutici SpA Basic Information, Pulmonary Administration Manufacturing Base, Sales Area and Its Competitors
Table 140. Chiesi Farmaceutici SpA Pulmonary Administration Product Portfolios and Specifications
Table 141. Chiesi Farmaceutici SpA Pulmonary Administration Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 142. Chiesi Farmaceutici SpA Main Business
Table 143. Chiesi Farmaceutici SpA Latest Developments
Table 144. Merck & Co, Inc Basic Information, Pulmonary Administration Manufacturing Base, Sales Area and Its Competitors
Table 145. Merck & Co, Inc Pulmonary Administration Product Portfolios and Specifications
Table 146. Merck & Co, Inc Pulmonary Administration Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 147. Merck & Co, Inc Main Business
Table 148. Merck & Co, Inc Latest Developments
Table 149. Novartis AG Basic Information, Pulmonary Administration Manufacturing Base, Sales Area and Its Competitors
Table 150. Novartis AG Pulmonary Administration Product Portfolios and Specifications
Table 151. Novartis AG Pulmonary Administration Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 152. Novartis AG Main Business
Table 153. Novartis AG Latest Developments
Table 154. PARI international Basic Information, Pulmonary Administration Manufacturing Base, Sales Area and Its Competitors
Table 155. PARI international Pulmonary Administration Product Portfolios and Specifications
Table 156. PARI international Pulmonary Administration Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 157. PARI international Main Business
Table 158. PARI international Latest Developments
Table 159. Vectura Group Plc Basic Information, Pulmonary Administration Manufacturing Base, Sales Area and Its Competitors
Table 160. Vectura Group Plc Pulmonary Administration Product Portfolios and Specifications
Table 161. Vectura Group Plc Pulmonary Administration Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 162. Vectura Group Plc Main Business
Table 163. Vectura Group Plc Latest Developments
Table 164. GlaxoSmithKline Basic Information, Pulmonary Administration Manufacturing Base, Sales Area and Its Competitors
Table 165. GlaxoSmithKline Pulmonary Administration Product Portfolios and Specifications
Table 166. GlaxoSmithKline Pulmonary Administration Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 167. GlaxoSmithKline Main Business
Table 168. GlaxoSmithKline Latest Developments
Table 169. Koninklijke Philips NV Basic Information, Pulmonary Administration Manufacturing Base, Sales Area and Its Competitors
Table 170. Koninklijke Philips NV Pulmonary Administration Product Portfolios and Specifications
Table 171. Koninklijke Philips NV Pulmonary Administration Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 172. Koninklijke Philips NV Main Business
Table 173. Koninklijke Philips NV Latest Developments
Table 174. OMRON Corporation Basic Information, Pulmonary Administration Manufacturing Base, Sales Area and Its Competitors
Table 175. OMRON Corporation Pulmonary Administration Product Portfolios and Specifications
Table 176. OMRON Corporation Pulmonary Administration Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 177. OMRON Corporation Main Business
Table 178. OMRON Corporation Latest Developments
Table 179. Sunovion Pharmaceuticals, Inc Basic Information, Pulmonary Administration Manufacturing Base, Sales Area and Its Competitors
Table 180. Sunovion Pharmaceuticals, Inc Pulmonary Administration Product Portfolios and Specifications
Table 181. Sunovion Pharmaceuticals, Inc Pulmonary Administration Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 182. Sunovion Pharmaceuticals, Inc Main Business
Table 183. Sunovion Pharmaceuticals, Inc Latest Developments
Table 184. Teva Pharmaceutical Industries Ltd Basic Information, Pulmonary Administration Manufacturing Base, Sales Area and Its Competitors
Table 185. Teva Pharmaceutical Industries Ltd Pulmonary Administration Product Portfolios and Specifications
Table 186. Teva Pharmaceutical Industries Ltd Pulmonary Administration Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 187. Teva Pharmaceutical Industries Ltd Main Business
Table 188. Teva Pharmaceutical Industries Ltd Latest Developments
Table 189. Yisuo Intelligent Basic Information, Pulmonary Administration Manufacturing Base, Sales Area and Its Competitors
Table 190. Yisuo Intelligent Pulmonary Administration Product Portfolios and Specifications
Table 191. Yisuo Intelligent Pulmonary Administration Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 192. Yisuo Intelligent Main Business
Table 193. Yisuo Intelligent Latest Developments
LIST OF FIGURES
Figure 1. Picture of Pulmonary Administration
Figure 2. Pulmonary Administration Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pulmonary Administration Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Pulmonary Administration Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Pulmonary Administration Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Pulmonary Administration Sales Market Share by Country/Region (2023)
Figure 10. Pulmonary Administration Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Pressurized Metered Dose Inhalation System
Figure 12. Product Picture of Dry Powder Inhalation System
Figure 13. Product Picture of Soft Mist Inhalation System
Figure 14. Product Picture of Others
Figure 15. Global Pulmonary Administration Sales Market Share by Type in 2023
Figure 16. Global Pulmonary Administration Revenue Market Share by Type (2019-2024)
Figure 17. Pulmonary Administration Consumed in Bronchial Asthma
Figure 18. Global Pulmonary Administration Market: Bronchial Asthma (2019-2024) & (K Units)
Figure 19. Pulmonary Administration Consumed in Chronic Obstructive Pulmonary Disease
Figure 20. Global Pulmonary Administration Market: Chronic Obstructive Pulmonary Disease (2019-2024) & (K Units)
Figure 21. Pulmonary Administration Consumed in Others
Figure 22. Global Pulmonary Administration Market: Others (2019-2024) & (K Units)
Figure 23. Global Pulmonary Administration Sale Market Share by Application (2023)
Figure 24. Global Pulmonary Administration Revenue Market Share by Application in 2023
Figure 25. Pulmonary Administration Sales by Company in 2023 (K Units)
Figure 26. Global Pulmonary Administration Sales Market Share by Company in 2023
Figure 27. Pulmonary Administration Revenue by Company in 2023 ($ millions)
Figure 28. Global Pulmonary Administration Revenue Market Share by Company in 2023
Figure 29. Global Pulmonary Administration Sales Market Share by Geographic Region (2019-2024)
Figure 30. Global Pulmonary Administration Revenue Market Share by Geographic Region in 2023
Figure 31. Americas Pulmonary Administration Sales 2019-2024 (K Units)
Figure 32. Americas Pulmonary Administration Revenue 2019-2024 ($ millions)
Figure 33. APAC Pulmonary Administration Sales 2019-2024 (K Units)
Figure 34. APAC Pulmonary Administration Revenue 2019-2024 ($ millions)
Figure 35. Europe Pulmonary Administration Sales 2019-2024 (K Units)
Figure 36. Europe Pulmonary Administration Revenue 2019-2024 ($ millions)
Figure 37. Middle East & Africa Pulmonary Administration Sales 2019-2024 (K Units)
Figure 38. Middle East & Africa Pulmonary Administration Revenue 2019-2024 ($ millions)
Figure 39. Americas Pulmonary Administration Sales Market Share by Country in 2023
Figure 40. Americas Pulmonary Administration Revenue Market Share by Country (2019-2024)
Figure 41. Americas Pulmonary Administration Sales Market Share by Type (2019-2024)
Figure 42. Americas Pulmonary Administration Sales Market Share by Application (2019-2024)
Figure 43. United States Pulmonary Administration Revenue Growth 2019-2024 ($ millions)
Figure 44. Canada Pulmonary Administration Revenue Growth 2019-2024 ($ millions)
Figure 45. Mexico Pulmonary Administration Revenue Growth 2019-2024 ($ millions)
Figure 46. Brazil Pulmonary Administration Revenue Growth 2019-2024 ($ millions)
Figure 47. APAC Pulmonary Administration Sales Market Share by Region in 2023
Figure 48. APAC Pulmonary Administration Revenue Market Share by Region (2019-2024)
Figure 49. APAC Pulmonary Administration Sales Market Share by Type (2019-2024)
Figure 50. APAC Pulmonary Administration Sales Market Share by Application (2019-2024)
Figure 51. China Pulmonary Administration Revenue Growth 2019-2024 ($ millions)
Figure 52. Japan Pulmonary Administration Revenue Growth 2019-2024 ($ millions)
Figure 53. South Korea Pulmonary Administration Revenue Growth 2019-2024 ($ millions)
Figure 54. Southeast Asia Pulmonary Administration Revenue Growth 2019-2024 ($ millions)
Figure 55. India Pulmonary Administration Revenue Growth 2019-2024 ($ millions)
Figure 56. Australia Pulmonary Administration Revenue Growth 2019-2024 ($ millions)
Figure 57. China Taiwan Pulmonary Administration Revenue Growth 2019-2024 ($ millions)
Figure 58. Europe Pulmonary Administration Sales Market Share by Country in 2023
Figure 59. Europe Pulmonary Administration Revenue Market Share by Country (2019-2024)
Figure 60. Europe Pulmonary Administration Sales Market Share by Type (2019-2024)
Figure 61. Europe Pulmonary Administration Sales Market Share by Application (2019-2024)
Figure 62. Germany Pulmonary Administration Revenue Growth 2019-2024 ($ millions)
Figure 63. France Pulmonary Administration Revenue Growth 2019-2024 ($ millions)
Figure 64. UK Pulmonary Administration Revenue Growth 2019-2024 ($ millions)
Figure 65. Italy Pulmonary Administration Revenue Growth 2019-2024 ($ millions)
Figure 66. Russia Pulmonary Administration Revenue Growth 2019-2024 ($ millions)
Figure 67. Middle East & Africa Pulmonary Administration Sales Market Share by Country (2019-2024)
Figure 68. Middle East & Africa Pulmonary Administration Sales Market Share by Type (2019-2024)
Figure 69. Middle East & Africa Pulmonary Administration Sales Market Share by Application (2019-2024)
Figure 70. Egypt Pulmonary Administration Revenue Growth 2019-2024 ($ millions)
Figure 71. South Africa Pulmonary Administration Revenue Growth 2019-2024 ($ millions)
Figure 72. Israel Pulmonary Administration Revenue Growth 2019-2024 ($ millions)
Figure 73. Turkey Pulmonary Administration Revenue Growth 2019-2024 ($ millions)
Figure 74. GCC Countries Pulmonary Administration Revenue Growth 2019-2024 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Pulmonary Administration in 2023
Figure 76. Manufacturing Process Analysis of Pulmonary Administration
Figure 77. Industry Chain Structure of Pulmonary Administration
Figure 78. Channels of Distribution
Figure 79. Global Pulmonary Administration Sales Market Forecast by Region (2025-2030)
Figure 80. Global Pulmonary Administration Revenue Market Share Forecast by Region (2025-2030)
Figure 81. Global Pulmonary Administration Sales Market Share Forecast by Type (2025-2030)
Figure 82. Global Pulmonary Administration Revenue Market Share Forecast by Type (2025-2030)
Figure 83. Global Pulmonary Administration Sales Market Share Forecast by Application (2025-2030)
Figure 84. Global Pulmonary Administration Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Pulmonary Administration
Figure 2. Pulmonary Administration Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pulmonary Administration Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Pulmonary Administration Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Pulmonary Administration Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Pulmonary Administration Sales Market Share by Country/Region (2023)
Figure 10. Pulmonary Administration Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Pressurized Metered Dose Inhalation System
Figure 12. Product Picture of Dry Powder Inhalation System
Figure 13. Product Picture of Soft Mist Inhalation System
Figure 14. Product Picture of Others
Figure 15. Global Pulmonary Administration Sales Market Share by Type in 2023
Figure 16. Global Pulmonary Administration Revenue Market Share by Type (2019-2024)
Figure 17. Pulmonary Administration Consumed in Bronchial Asthma
Figure 18. Global Pulmonary Administration Market: Bronchial Asthma (2019-2024) & (K Units)
Figure 19. Pulmonary Administration Consumed in Chronic Obstructive Pulmonary Disease
Figure 20. Global Pulmonary Administration Market: Chronic Obstructive Pulmonary Disease (2019-2024) & (K Units)
Figure 21. Pulmonary Administration Consumed in Others
Figure 22. Global Pulmonary Administration Market: Others (2019-2024) & (K Units)
Figure 23. Global Pulmonary Administration Sale Market Share by Application (2023)
Figure 24. Global Pulmonary Administration Revenue Market Share by Application in 2023
Figure 25. Pulmonary Administration Sales by Company in 2023 (K Units)
Figure 26. Global Pulmonary Administration Sales Market Share by Company in 2023
Figure 27. Pulmonary Administration Revenue by Company in 2023 ($ millions)
Figure 28. Global Pulmonary Administration Revenue Market Share by Company in 2023
Figure 29. Global Pulmonary Administration Sales Market Share by Geographic Region (2019-2024)
Figure 30. Global Pulmonary Administration Revenue Market Share by Geographic Region in 2023
Figure 31. Americas Pulmonary Administration Sales 2019-2024 (K Units)
Figure 32. Americas Pulmonary Administration Revenue 2019-2024 ($ millions)
Figure 33. APAC Pulmonary Administration Sales 2019-2024 (K Units)
Figure 34. APAC Pulmonary Administration Revenue 2019-2024 ($ millions)
Figure 35. Europe Pulmonary Administration Sales 2019-2024 (K Units)
Figure 36. Europe Pulmonary Administration Revenue 2019-2024 ($ millions)
Figure 37. Middle East & Africa Pulmonary Administration Sales 2019-2024 (K Units)
Figure 38. Middle East & Africa Pulmonary Administration Revenue 2019-2024 ($ millions)
Figure 39. Americas Pulmonary Administration Sales Market Share by Country in 2023
Figure 40. Americas Pulmonary Administration Revenue Market Share by Country (2019-2024)
Figure 41. Americas Pulmonary Administration Sales Market Share by Type (2019-2024)
Figure 42. Americas Pulmonary Administration Sales Market Share by Application (2019-2024)
Figure 43. United States Pulmonary Administration Revenue Growth 2019-2024 ($ millions)
Figure 44. Canada Pulmonary Administration Revenue Growth 2019-2024 ($ millions)
Figure 45. Mexico Pulmonary Administration Revenue Growth 2019-2024 ($ millions)
Figure 46. Brazil Pulmonary Administration Revenue Growth 2019-2024 ($ millions)
Figure 47. APAC Pulmonary Administration Sales Market Share by Region in 2023
Figure 48. APAC Pulmonary Administration Revenue Market Share by Region (2019-2024)
Figure 49. APAC Pulmonary Administration Sales Market Share by Type (2019-2024)
Figure 50. APAC Pulmonary Administration Sales Market Share by Application (2019-2024)
Figure 51. China Pulmonary Administration Revenue Growth 2019-2024 ($ millions)
Figure 52. Japan Pulmonary Administration Revenue Growth 2019-2024 ($ millions)
Figure 53. South Korea Pulmonary Administration Revenue Growth 2019-2024 ($ millions)
Figure 54. Southeast Asia Pulmonary Administration Revenue Growth 2019-2024 ($ millions)
Figure 55. India Pulmonary Administration Revenue Growth 2019-2024 ($ millions)
Figure 56. Australia Pulmonary Administration Revenue Growth 2019-2024 ($ millions)
Figure 57. China Taiwan Pulmonary Administration Revenue Growth 2019-2024 ($ millions)
Figure 58. Europe Pulmonary Administration Sales Market Share by Country in 2023
Figure 59. Europe Pulmonary Administration Revenue Market Share by Country (2019-2024)
Figure 60. Europe Pulmonary Administration Sales Market Share by Type (2019-2024)
Figure 61. Europe Pulmonary Administration Sales Market Share by Application (2019-2024)
Figure 62. Germany Pulmonary Administration Revenue Growth 2019-2024 ($ millions)
Figure 63. France Pulmonary Administration Revenue Growth 2019-2024 ($ millions)
Figure 64. UK Pulmonary Administration Revenue Growth 2019-2024 ($ millions)
Figure 65. Italy Pulmonary Administration Revenue Growth 2019-2024 ($ millions)
Figure 66. Russia Pulmonary Administration Revenue Growth 2019-2024 ($ millions)
Figure 67. Middle East & Africa Pulmonary Administration Sales Market Share by Country (2019-2024)
Figure 68. Middle East & Africa Pulmonary Administration Sales Market Share by Type (2019-2024)
Figure 69. Middle East & Africa Pulmonary Administration Sales Market Share by Application (2019-2024)
Figure 70. Egypt Pulmonary Administration Revenue Growth 2019-2024 ($ millions)
Figure 71. South Africa Pulmonary Administration Revenue Growth 2019-2024 ($ millions)
Figure 72. Israel Pulmonary Administration Revenue Growth 2019-2024 ($ millions)
Figure 73. Turkey Pulmonary Administration Revenue Growth 2019-2024 ($ millions)
Figure 74. GCC Countries Pulmonary Administration Revenue Growth 2019-2024 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Pulmonary Administration in 2023
Figure 76. Manufacturing Process Analysis of Pulmonary Administration
Figure 77. Industry Chain Structure of Pulmonary Administration
Figure 78. Channels of Distribution
Figure 79. Global Pulmonary Administration Sales Market Forecast by Region (2025-2030)
Figure 80. Global Pulmonary Administration Revenue Market Share Forecast by Region (2025-2030)
Figure 81. Global Pulmonary Administration Sales Market Share Forecast by Type (2025-2030)
Figure 82. Global Pulmonary Administration Revenue Market Share Forecast by Type (2025-2030)
Figure 83. Global Pulmonary Administration Sales Market Share Forecast by Application (2025-2030)
Figure 84. Global Pulmonary Administration Revenue Market Share Forecast by Application (2025-2030)
